Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

NCT06340789 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Symptom, Cognitive
Schizophrenia
Schizo Affective Disorder

Interventions

DRUG: Sodium Benzoate 2gram/day
DRUG: Placebo

Sponsor

National Cheng-Kung University Hospital